Etoposide Injection
Product Images NDC 0143-9376

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 0143-9376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Etoposide Injection Usp Novaplus 1)

FDA Label Image

Etoposide Injection, Usp 100 mg/5 mL Label (Etoposide Injection Usp Novaplus 2)

Etoposide Injection, Usp 100 mg/5 mL Label (Etoposide Injection Usp Novaplus 2)
This is a description of a medication called Etoposide, with the unique identifier code of NOC 0143-9976-01. The medication is given as an injectable solution with a usual dosage of 50 mg. The solution must be diluted before use and stored between 20°C and 25°C. The medication is distributed by Hha Phamiceutls USA in Eatontown, New Jersey.*
FDA Label Image

Representative Serialization Image (Etoposide Injection Usp Novaplus 3)

Representative Serialization Image (Etoposide Injection Usp Novaplus 3)
This is a product identification code. It includes a GTIN (Global Trade Item Number), SN (Serial Number), EXP (Expiration) date, and LOT (Lot Number). Without additional context, it is impossible to determine the specific product or industry to which this code refers.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.